Carlos Luis Lopez's most recent trade in Niagen Bioscience Inc. was a trade of 273 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Carlos Luis Lopez | SVP, General Counsel | Purchase of securities on an exchange or from another person at price $ 7.86 per share. | 07 Mar 2025 | 273 | 2,251 (0%) | 0% | 7.9 | 2,146 | Common Stock |
| Niagen Bioscience Inc. | Carlos Luis Lopez | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,691 | 19,691 | - | - | Employee Stock Options (right to buy) |